4
Changes in Ownership
LB PHARMACEUTICALS INC Filed Acc 0001415889-25-024442
Options or other derivatives
- Chief Executive Officer acquired 1,155,391 shares (grant or award)
- Chief Executive Officer returned 183,563 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Turner Heather D Chief Executive Officer | 2025-09-10 | Returned to the company · Employee Stock Option (Right to Buy) | −175,706 | 0 | D | ||
| Turner Heather D Chief Executive Officer | 2025-09-10 | Grant or award · Employee Stock Option (Right to Buy) | +175,706 | 175,706 | D | ||
| Turner Heather D Chief Executive Officer | 2025-09-10 | Returned to the company · Employee Stock Option (Right to Buy) | −7,857 | 0 | D | ||
| Turner Heather D Chief Executive Officer | 2025-09-10 | Grant or award · Employee Stock Option (Right to Buy) | +7,857 | 7,857 | D | ||
| Turner Heather D Chief Executive Officer | 2025-09-10 | Grant or award · Employee Stock Option (Right to Buy) | +971,828 | 971,828 | D | ||
Loading xslF345X05/form4-09122025_060901.xml…